BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Gupta T, Jarpula NS. Hepatocellular carcinoma immune microenvironment and check point inhibitors-current status. World J Hepatol 2024; 16(3): 353-365 [PMID: 38577535 DOI: 10.4254/wjh.v16.i3.353]
URL: https://www.wjgnet.com/1948-5182/full/v16/i3/353.htm
Number Citing Articles
1
Jiayun Chen, Wenmin Lu, Yanni Lou, Jing Liu, Xiwen Liao, Yunmeng Bai, Guangqing Cheng, Guangzhi Zhu, Ji Feng, Junqi Liu, Zhaoji Liu, Liqun Jia, Jing Zhou, Tao Peng, Guo-Dong Lu, Jigang Wang. Integrating single cell- and spatial- resolved transcriptomics unravels the inter-tumor heterogeneity and immunosuppressive landscape in HBV- and Clonorchis sinensis-associated hepatocellular carcinomaMolecular Cancer 2026; 25(1) doi: 10.1186/s12943-025-02381-z
2
铭阳 唐. Current Research Status and Prospects of Immunotherapy Advances in Hepatocellular CarcinomaAdvances in Clinical Medicine 2025; 15(01) doi: 10.12677/acm.2025.151037
3
Rohan Karkra, Ahmed Al-Khazraji. Nanobodies and precision delivery in gastroenterology: promise, pragmatism and the path forwardConsiderations in Medicine 2026; 4(1) doi: 10.1136/conmed-2026-000042
4
Leonardo Stella, Giuseppe Cabibbo, Ciro Celsa, Roberta Ciccia, Alba Sparacino, Fabio Piscaglia, Francesco Tovoli, Andrea Arleo, Bernardo Stefanini, Massimo Iavarone, Roberta D'Ambrosio, Lucia Cerrito, Maria Pallozzi, Francesco Santopaolo, Fabio Marra, Claudia Campani, Chiara Mazzarelli, Raffaella Viganò, Raffaella Tortora, Alessio Aghemo, Stella De Nicola, Tiziana Pressiani, Lorenza Rimassa, Sherrie Bhoori, Salvatore Corallo, Laura Maiocchi, Andrea Martini, Caterina Soldà, Francesco Paolo Russo, Antonio Gasbarrini, Francesca Romana Ponziani. Hepatitis C Eradication Improves Oncologic and Clinical Outcomes in Patients Treated With Atezolizumab Plus BevacizumabLiver International 2025; 45(10) doi: 10.1111/liv.70362
5
Vivek K. Kashyap, Bhuvnesh P. Sharma, Himanshu N. Singh, Sanjay Kumar, Deepak Verma, Deepak Parashar, Murali M. Yallapu, Everardo Cobos, Subhash C. Chauhan. Bioinformatics analysis of TRPV1 expression and its role in hepatocellular carcinoma prognosisDiscover Oncology 2026; 17(1) doi: 10.1007/s12672-026-04744-4
6
Xinxin Wang, Zhe Hu, Jiaxuan Ding, Suyongde Zheng, Bangcheng Wei, Yang Zhou, Shuhong Wang. Prognostic Nomogram for Hepatocellular Carcinoma Patients with High Systemic Immune-Inflammation Index: Validation in Surgical and Immunotherapy Cohorts and Exploration of Immune Microenvironment MechanismsJournal of Hepatocellular Carcinoma 2026;  doi: 10.2147/JHC.S588390
7
Bangyan L. Stiles. A targeted liver cancer therapy independent of immune checkpoint blockHepatology 2026; 84(2) doi: 10.1097/HEP.0000000000001543
8
Konstantina Dimopoulou, Aris Spathis, Christina Papamichail, Aikaterini Athanasiadou, Abraham Pouliakis, Christakis Risilia, Despoina Myoteri, Panayiotis Kokoropoulos, Manousos Konstantoulakis, Ioannis G. Panayiotides, Nikolaos Arkadopoulos, Dina Tiniakos, Periklis G. Foukas. Antigen-specific CD8+CD39+ cytotoxic T cell density in the microenvironment of hepatocellular carcinoma predicts patient survivalBritish Journal of Cancer 2026; 134(3) doi: 10.1038/s41416-025-03226-8
9
Ioannis Tsomidis, Argyro Voumvouraki, Elias Kouroumalis. Immune Checkpoints and the Immunology of Liver FibrosisLivers 2025; 5(1) doi: 10.3390/livers5010005
10
Maria Stella Franzè, Francesca Saffioti, Vasileios K. Mavroeidis. Interactions between tumor microenvironment and resistance to transarterial and systemic treatments for HCCCancer Drug Resistance 2025;  doi: 10.20517/cdr.2024.212
11
Xiang Li, Donghao Yin, Jiahao Geng, Yanyu Xu, Zijing Xu, Xuemeng Yang, Quanwei Li, Zimeng Shang, Zhiyun Yang, Zhong Xu, Jiabo Wang, Enxiang Zhang, Xinhua Song. Machine learning-driven multi-omics analysis identifies a prognostic gene signature associated with programmed cell death and metabolism in hepatocellular carcinomaBiological Procedures Online 2025; 27(1) doi: 10.1186/s12575-025-00286-1
12
Héctor Vázquez-Lorente, Jorge Olivares-Arancibia, Julio Plaza-Diaz. Beyond the score: Diet and exercise as modifiers of inflammation-based prognosis in lenvatinib-treated hepatocellular carcinomaWorld Journal of Gastroenterology 2026; 32(22): 118191 doi: 10.3748/wjg.v32.i22.118191
13
Ye Tan, Jingxuan Xiang, Zehan Wang, Yu Wang, Aidong Chen, Qiwen Wu. Development and Validation of a Six-Gene Signature of Myeloid Antigen Presentation Dysfunction Based on Single-Cell and Multi-Cohort Transcriptomics for Predicting Prognosis and Recurrence of Hepatocellular CarcinomaCancer Informatics 2026; 25 doi: 10.1177/11769351261466300
14
Rong-Quan He, Zhen-Bo Feng, Gang Chen, Di-Yuan Qin, Lin-Qing Huang, Qin-Yan Su, Bang-Teng Chi, Yu-Lu Tang, Da-Tong Zeng, Gao-Peng Yao, Jia-Le Wang, Fu-Xi Li, Yu-Xing Tang, Xiao-Wei Wang. Clinical significance of upregulated Rho GTPase activating protein 12 causing resistance to tyrosine kinase inhibitors in hepatocellular carcinomaWorld Journal of Gastrointestinal Oncology 2024; 16(10): 4244-4263 doi: 10.4251/wjgo.v16.i10.4244
15
Zehao Li, Boqiang Zhong, Qian Zhang, Lin Sun, Xiaoxiao Li, Xiao Hu, Dawei Chen. Multiomics Analysis Identifies Chromosomal Instability‐Associated Immune‐Related Signatures in Hepatocellular Carcinoma by Integrating Weighted Gene Coexpression Network Analysis (WGCNA) and Machine LearningHuman Mutation 2026; 2026(1) doi: 10.1155/humu/6594696